These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8145468)

  • 41. [The mechanism of the action of dalargin in experimental myocardial ischemia].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Glushchenko NV; Semushkina TM
    Biull Eksp Biol Med; 1992 Oct; 114(10):345-7. PubMed ID: 1288681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The antioxidant action of dalargin on the liver in experimental acute cholestasis].
    Korotkina RN; Fomchenkov EP; Babkina NV; Andreev VI; Shloznikov BM; Karelin AA
    Patol Fiziol Eksp Ter; 1990; (4):42-4. PubMed ID: 2080086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of the hexapeptide dalargin on ornithine decarboxylase activity in the duodenal mucosa of rats in experimental duodenal ulcer].
    Iarygin KN; Shitin AG; Polonskiĭ VM; Vinogradov VA
    Biull Eksp Biol Med; 1987 Mar; 103(3):319-21. PubMed ID: 3828514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical site infections: epidemiology, microbiology and prevention.
    Owens CD; Stoessel K
    J Hosp Infect; 2008 Nov; 70 Suppl 2():3-10. PubMed ID: 19022115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Surgical treatment of suppurative anterior mediastinitis after open heart surgery for congenital defects].
    Latsis AT; Zandersons KhA; Ozols AIa; Volkolakov IaV
    Vestn Khir Im I I Grek; 1984 Feb; 132(2):21-4. PubMed ID: 6719712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dalargin in the therapy of the exacerbations of chronic pancreatitis].
    Geller LI; Kazakevich VV; Pashko MM
    Ter Arkh; 1992; 64(8):80-2. PubMed ID: 1279830
    [No Abstract]   [Full Text] [Related]  

  • 47. Basic aspects of and general problems in surgical infections.
    Fry DE
    Surg Infect (Larchmt); 2001; 2 Suppl 1():S3-11. PubMed ID: 12594860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The evaluation of the efficacy of dalargin treatment in patients with face and neck phlegmons by the free-radical oxidation indices of the peripheral blood].
    Ganina SS; Ragimov ChR
    Stomatologiia (Mosk); 1991; (6):28-30. PubMed ID: 1803645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of peptic ulcer hemorrhage with leucine enkephalin analog dalargin].
    Georgadze AK; Fomin VB; Bulgakov SA; Fedenko VV
    Khirurgiia (Mosk); 1990 Mar; (3):39-43. PubMed ID: 2193190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current approaches to the prevention of infectious complications in heart surgery].
    Bogomolova NS; Abbakumov VV; Stepanenko RN; Potekhina AD; Pkhakadze TIa; Vinogradova LN
    Khirurgiia (Mosk); 1993 Feb; (2):46-53. PubMed ID: 8084151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of dalargin on repair capacity of gastroduodenal mucosa in patients with duodenal ulcer].
    Timoshin SS; Alekseenko SA; Shtuka AA
    Klin Med (Mosk); 1991 Mar; 69(3):75-7. PubMed ID: 2067344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Intraoperative bacteriological examination of patients operated on under extracorporeal circulation].
    Bogomolova NS; Pkhakadze TIa
    Antibiot Khimioter; 1989 Sep; 34(9):701-5. PubMed ID: 2514631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Opioid hexapeptide dalargin in the pathogenetic therapy of diseases of the digestive organs].
    Vinogradov VA; Buglak NP
    Sov Med; 1988; (10):59-63. PubMed ID: 3071859
    [No Abstract]   [Full Text] [Related]  

  • 54. [Preparation of the operating field in patients with congenital or acquired heart diseases in surgery with extracorporeal circulation].
    Krupacz R
    Wiad Lek; 1971 Sep; 24(17):1603-6. PubMed ID: 5116435
    [No Abstract]   [Full Text] [Related]  

  • 55. [The inhibitory effect of the synthetic leu-enkephalin analog dalargin on carcinogenesis].
    Anisimov VN; Bortkevich SM
    Vopr Onkol; 1990; 36(5):556-9. PubMed ID: 2378078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Control of lymph-drainage tracts of the eye by the use of dalargin].
    Rapis EG; Tumanov VP; Levin IuM; Kurbanov NKh
    Biull Eksp Biol Med; 1990 Oct; 110(10):436-8. PubMed ID: 2279106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Restriction of functional disorders by the use of a regulatory peptide dalargin in burned rats infected with Staphylococcus aureus].
    Pashutin SB
    Biull Eksp Biol Med; 1990 Jul; 110(7):24-6. PubMed ID: 2224089
    [No Abstract]   [Full Text] [Related]  

  • 58. [Dalargin in the prevention of acute postoperative pancreatitis].
    Grigorevskiĭ VP; Korotkina RN; Pomelov VS; Shloznikov BM; Karelin AA
    Klin Khir (1962); 1989; (11):9-12. PubMed ID: 2640568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Blood flow in skin wound tissue and systemic hemodynamics as affected by a collagen-dalargin complex].
    Medvedev OS; Khulup GIa; Spevak SE; Istranov LP; Titov MI
    Biull Eksp Biol Med; 1987 Dec; 104(12):651-4. PubMed ID: 2446676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The effect of the synthetic leu-enkephalin analog dalargin on the proliferative activity of glioma C6 cells and on the intensity of their DNA synthesis].
    Slepko NG; Kozlova MV
    Tsitologiia; 1992; 34(1):66-73. PubMed ID: 1636213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.